Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Glencore chief Ivan Glasenberg plans to raise $2.5 billion; Investors push into restructure on debt fears

  Mounting pressure from investors has forced debt-laden commodities giant Glencore into a $US2.5 billion ($3.6 billion) equity raising to protect its investment grade credit rating, which is needed to underpin its trading business, from being downgraded to junk status. Less than three weeks after Glencore’s chief executive Ivan Glasenberg boasted about the miner’s ability […]

Ivan Glasenberg

 

Mounting pressure from investors has forced debt-laden commodities giant Glencore into a $US2.5 billion ($3.6 billion) equity raising to protect its investment grade credit rating, which is needed to underpin its trading business, from being downgraded to junk status.

Less than three weeks after Glencore’s chief executive Ivan Glasenberg boasted about the miner’s ability to cover its dividend with free cash flow, unlike some of its rivals, the trading giant has suspended its dividend until further notice, beginning with the final payment for the 2014-15 year and its interim dividend for 2016.
That measure will save the group a further $US2.4 billion, as part of its new remedy plan to grab $US10.2 billion in “savings”, to cut its $US29.6 billion net debt by about a third.

It could be a fatal blow for Glencore’s designs on rival Rio Tinto, which it wanted to take out through an all-scrip “merger of equals”.
Advertisement

Glencore’s share price has been savaged since it posted an interim net loss in August, and it failed to allay investor and analyst concerns that it was not doing enough to deal with its huge debt.

Read the full story at SMH, by Amanda Saunders

 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

empty

The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...

Business

Now Platika joins and elite club of $10 billion plus Israeli firms.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

Advertisement